CAS 105250-86-0 Ebiratide

Send Inquiry
CAS 105250-86-0 Ebiratide
Details
Ebiratide;
Category: Neurotrophic/neuroprotective peptide analogue.
Peptide Purity (HPLC) ≥95%
CAS No. 105250-86-0
Structure Synthetic octapeptide neuroprotective analogue (Ebiratide)
Solubility Water, dilute acetic acid/saline
Storage Powder, −20°C, dry, light-protected
Category
Neuropeptide
Share to
Description

Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of cas 105250-86-0 ebiratide in China, also supports custom service. Welcome to wholesale bulk high quality cas 105250-86-0 ebiratide from our factory. Contact us for more details.

 

  ↵

Description A synthetic octapeptide neurotrophin-domain analogue (YM-691) with neurotrophic and neuroprotective effects studied in neurodegeneration.

 

Product Basic Information Table

 

Standard English Name Abbreviation/Synonym Function Tags (comma-separated) Core Structure Molecular Formula Exact Mass (Da) Average MW (Da) Salt Form Length (aa)
Ebitiride, CAS 105250-86-0 Ebiratide (catalog name 'Ebitiride' is a spelling variant); HOE 427; HOE-427; ACTH(4-9) analog; Met(O2)-Glu-His-Phe-D-Lys-Phe-NH(CH2)8NH2; MEHFKF; HY-19648; TP2379; PEP-EBIT-01 neuropeptide, ACTH(4-9) analog, nootropic / anti-amnestic, central nervous system, blood-brain barrier transport, melanocortin-related peptide, methionine sulfone modification, 8-aminooctylamide, CAS reference standard Modified hexapeptide: H-Met(O2)-Glu-His-Phe-D-Lys-Phe-NH-(CH2)8-NH2 (backbone one-letter MEHFKF; position 1 Met is S,S-dioxidized to methionine sulfone / methylsulfonyl-ethyl side chain; position 5 is D-lysine; the C-terminal Phe is capped as an 8-aminooctylamide, -Phe-NH-(CH2)8-NH2); free N-terminal amine and free Glu side-chain carboxyl; no disulfide bond, no N-acetylation. Relative to parent ACTH(4-9) (Met-Glu-His-Phe-Arg-Trp): Arg→D-Lys, Trp→Phe with octylamide extension, and Met oxidized to sulfone to enhance proteolytic stability and brain penetration. PubChem systematic name: N-[(2S)-2-amino-4-(methylsulfonyl)butanoyl]-L-α-glutamyl-L-histidyl-L-phenylalanyl-D-lysyl-N-(8-aminooctyl)-L-phenylalaninamide. Note: non-standard modifications (Met sulfone, D-residue, octylamide) cannot be modeled by the standard linear-peptide calculator; formula and MW are taken from the CAS-registered structure and were not recomputed on a plain peptide backbone. C48H73N11O10S 995.53 996.23 Free peptide base (CAS 105250-86-0; PubChem CID 6918103 registers C48H73N11O10S); clinical/other catalog forms are the triacetate (HOE-427 triacetate, CAS 115994-46-2, C54H85N11O16S, MW ≈1176.39; some suppliers cite 105611-68-5) and TFA salt; actual delivered salt form per COA. 6

 

Physicochemical Solubility & Storage Parameters

 

Product Code Appearance Long-term Storage Short-term Storage Solution Stability Solid Powder Stability
PEP-EBIT-01 White to off-white powder (peptide salt form; if acetate/TFA salt it is hygroscopic - reseal immediately, keep in a desiccator and weigh rapidly). Store at −20°C, sealed and dry; aliquot to avoid repeated freeze-thaw; ~2–3 years. Met is already in the sulfone state - no further oxidation risk; no free Cys/Trp/Tyr, so no disulfide-mismatch or special light-protection requirement. If acetate/TFA salt - keep in a desiccator. 2–8°C, sealed and dry, for ~2 weeks; working aliquots at −20°C; ship on blue ice, moisture-protected. Amphipathic small peptide (His/Glu/Lys plus terminal primary amine); soluble in water or neutral buffers (PBS pH 7.4); if needed, assist dissolution with dilute AcOH or a small amount of DMSO, then dilute to 1–2 mg/mL and filter through 0.22 μm. Prepare fresh; ≤1 week at 2–8°C, aliquot and store ≤3 months at −20°C; ≤3 freeze-thaw cycles; avoid pH>8. The triacetate/TFA form is usually more water-soluble; salt form per COA. solid stable ~2–3 years at −20°C, sealed and dry. The Met sulfone does not oxidize further; no Cys/Trp/Tyr. If acetate/TFA salt - protect from moisture.

 

Functional Description

 

Product Code Front-end Short Summary Detailed Biological Function Research Areas (comma-separated) Targets / Receptors
PEP-EBIT-01 Ebiratide (HOE 427; catalog 'Ebitiride' is a spelling variant), a modified ACTH(4-9) hexapeptide H-Met(O2)-Glu-His-Phe-D-Lys-Phe-NH(CH2)8NH2, CAS 105250-86-0 (C48H73N11O10S, MW 995.53/996.23); a central nootropic/anti-amnestic agent that crosses the BBB by absorptive-mediated endocytosis and enhances brain acetylcholine metabolism, lacking the corticotropic activity of parent ACTH. Ebiratide (development code HOE 427; INN Ebiratide; the batch catalog name 'Ebitiride' is a spelling variant) is a synthetic adrenocorticotropic hormone ACTH(4-9) analog used in neuroscience research. Relative to the ACTH(4-9) fragment (Met-Glu-His-Phe-Arg-Trp), three stabilizing changes were made: the N-terminal Met is oxidized to methionine sulfone (Met(O2), S,S-dioxide) to resist oxidative deamination; position 8 Arg is replaced by D-Lys; and position 9 Trp is replaced by Phe capped with an 8-aminooctylamide (-Phe-NH-(CH2)8-NH2), improving proteolytic stability and blood-brain barrier penetration. Pharmacologically, ebiratide acts directly on the CNS, showing learning/memory-enhancing and anti-amnestic (nootropic) effects in ECS- or scopolamine-induced amnesia models in mice and rats, and enhances acetylcholine (ACh) metabolism in rat brain. It crosses the BBB via a saturable, absorptive-mediated endocytic pathway (isolated brain capillaries: Bmax ≈144.2 pmol/mg protein, Kd ≈62.1 μM), yielding higher brain-interstitial-fluid concentrations than a restricted transport marker. As a melanocortin-related short peptide, its behavioral effects are mediated mainly through central cholinergic and melanocortin-receptor pathways, and it lacks the corticotropic (corticosterone-secreting) activity of parent ACTH. CAS 105250-86-0 is registered as the free base C48H73N11O10S by PubChem (CID 6918103) and TargetMol (TP2379): monoisotopic 995.53 / average 996.23 Da; MCE (HY-19648) lists the same formula and MW. Note: this product carries non-standard modifications (Met sulfone, D-Lys, octylamide); its formula and MW are taken from the CAS-registered structure and were not recomputed on a plain linear-peptide backbone. The clinical triacetate (CAS 115994-46-2, C54H85N11O16S, MW ≈1176.39) and TFA salt are alternate salt forms; actual delivery per COA. neuroscience, nootropic / learning-and-memory research, anti-amnestic models (ECS/scopolamine), blood-brain barrier transport mechanisms, central cholinergic pathways, ACTH/melanocortin analog pharmacology central melanocortin-receptor-related pathways; central cholinergic (acetylcholine metabolism) pathways; absorptive-mediated BBB transport sites (not the peripheral adrenal cortical receptor)

 

 

 

 

Hot Tags: cas 105250-86-0 ebiratide, China cas 105250-86-0 ebiratide manufacturers, suppliers, factory, 94071-26-8, CAS 94071 26 8, Cerebellin, neuropeptide

Send Inquiry